Missense mutations therefore enhance tumor development and progression in three ways: the loss of wild‐type‐like DNA binding activity (loss of function, LOF), dominant‐negative effects on wild‐type p53, and the gain of new tumor‐promoting oncogenic properties (gain of function, GOF) (Stiewe & Haran, 2018). Here, TP53 is linked to neoplasm.